{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:42:36Z","timestamp":1792698156867,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012479","name":"Weston Brain Institute","doi-asserted-by":"publisher","award":["TR192043"],"award-info":[{"award-number":["TR192043"]}],"id":[{"id":"10.13039\/100012479","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.neurobiolaging.2024.12.001","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T11:29:19Z","timestamp":1733830159000},"page":"49-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Procognitive and neurotrophic benefits of \u03b15-GABA-A receptor positive allosteric modulation in a \u03b2-amyloid deposition mouse model of Alzheimer\u2019s disease pathology"],"prefix":"10.1016","volume":"147","author":[{"given":"Ashley M.","family":"Bernardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Marcotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dishary","family":"Sharmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal P.","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne L.","family":"Sibille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Prevot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.neurobiolaging.2024.12.001_bib1","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archneur.65.11.1509","article-title":"Frequent amyloid deposition without significant cognitive impairment among the elderly","author":"Aizenstein","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2024.12.001_bib2","doi-asserted-by":"crossref","unstructured":"Amram, S., Frenkel, D. Chapter 3 - Animal Models of Alzheimer\u2019s Disease. 2017; https:\/\/doi.org\/10.1016\/B978-0-12-803690-7.00003-X.","DOI":"10.1016\/B978-0-12-803690-7.00003-X"},{"issue":"11","key":"10.1016\/j.neurobiolaging.2024.12.001_bib3","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1111\/cns.13914","article-title":"Effects of \u03b15 GABA(A) receptor modulation on social interaction, memory, and neuroinflammation in a mouse model of Alzheimer's disease","author":"Aran\u0111elovi\u0107","year":"2022","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neurobiolaging.2024.12.001_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.5114\/fn.2019.85929","article-title":"R. Risk factors for Alzheimer\u2019s disease","volume":"2","author":"Armstrong","year":"2019","journal-title":"Folia Neuropathol."},{"issue":"9","key":"10.1016\/j.neurobiolaging.2024.12.001_bib5","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1038\/s41386-022-01360-y","article-title":"Symptomatic and neurotrophic effects of GABAA receptor positive allosteric modulation in a mouse model of chronic stress","author":"Bernardo","year":"2022","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/j.neurobiolaging.2024.12.001_bib6","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1038\/s41386-022-01360-y","article-title":"Symptomatic and neurotrophic effects of GABAA receptor positive allosteric modulation in a mouse model of chronic stress","author":"Bernardo","year":"2022","journal-title":"Neuropsychopharmacology"},{"issue":"18","key":"10.1016\/j.neurobiolaging.2024.12.001_bib7","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/0024-3205(92)90534-V","article-title":"Somatostatin in Alzheimer's disease and depression","author":"Bissette","year":"1992","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2024.12.001_bib8","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/ana.25049","article-title":"Dendritic spines provide cognitive resilience against Alzheimer's disease","author":"Boros","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2024.12.001_bib9","article-title":"Synaptic pruning in Alzheimer's disease: role of the complement system","volume":"6","author":"Brucato","year":"2020","journal-title":"Glob. J. Med. Res."},{"key":"10.1016\/j.neurobiolaging.2024.12.001_bib10","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1080\/13607863.2017.1387760","article-title":"Psychosocial risk factors and Alzheimer's disease: the associative effect of depression, sleep disturbance, and anxiety","volume":"12","author":"Burke","year":"2018","journal-title":"Aging Ment. Health"},{"issue":"5788","key":"10.1016\/j.neurobiolaging.2024.12.001_bib11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/288279a0","article-title":"Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa","author":"Davies","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2024.12.001_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2019.172837","article-title":"Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine","author":"Deyama","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2024.12.001_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-015-1449-5","article-title":"Analyzing dendritic spine pathology in Alzheimer's disease: problems and opportunities","author":"Dorostkar","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2024.12.001_bib14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1750-1326-8-2","article-title":"Neuron loss in the 5XFAD mouse model of Alzheimer's disease correlates with intraneuronal A\u03b242 accumulation and Caspase-3 activation","author":"Eimer","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neurobiolaging.2024.12.001_bib15","first-page":"245","article-title":"Hippocampal injections of oligomeric amyloid \u03b2-peptide (1-42) induce selective working memory deficits and long-lasting alterations of ERK signaling pathway","author":"Faucher","year":"2015","journal-title":"Front Aging Neurosci."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2024.12.001_bib16","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/cne.903590111","article-title":"GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits","author":"Fritschy","year":"1995","journal-title":"J. Comp. Neurol."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2024.12.001_bib17","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1172\/JCI130808","article-title":"GABA interneurons are the cellular trigger for ketamine's rapid antidepressant actions","author":"Gerhard","year":"2020","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2024.12.001_bib18","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3233\/JAD-2012-120982","article-title":"Evidence for early cognitive impairment related to frontal cortex in the 5XFAD mouse model of Alzheimer's disease","author":"Girard","year":"2013","journal-title":"J. Alzheimers Dis."},{"issue":"22","key":"10.1016\/j.neurobiolaging.2024.12.001_bib19","doi-asserted-by":"crossref","first-page":"8704","DOI":"10.3390\/ijms21228704","article-title":"Impaired expression of GABA signaling components in the Alzheimer's disease middle temporal gyrus","author":"Govindpani","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.neurobiolaging.2024.12.001_bib20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.brainresbull.2017.12.013","article-title":"Myelin changes at the early stage of 5XFAD mice","author":"Gu","year":"2018","journal-title":"Brain Res. Bull."},{"issue":"7","key":"10.1016\/j.neurobiolaging.2024.12.001_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001694","article-title":"If amyloid drives Alzheimer disease, why have anti-amyloid therapies not yet slowed cognitive decline?","author":"Haass","year":"2022","journal-title":"PLoS Biol."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2024.12.001_bib22","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0306-4522(00)00163-9","article-title":"Density and pharmacology of alpha5 subunit-containing GABA(A) receptors are preserved in hippocampus of Alzheimer's disease patients","author":"Howell","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2024.12.001_bib23","first-page":"204","article-title":"Cell type-specific gene expression of alpha 5 subunit-containing gamma-aminobutyric acid subtype A receptors in human and mouse frontal cortex","volume":"4","author":"Hu","year":"2019","journal-title":"Mol. Neuropsychiatry"},{"key":"10.1016\/j.neurobiolaging.2024.12.001_bib24","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3389\/fnins.2019.00735","article-title":"Targeting the synapse in Alzheimer's disease","author":"Jackson","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2024.12.001_bib25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3389\/fnmol.2019.00179","article-title":"Neurobiology and therapeutic potential of alpha5-GABA type A receptors","author":"Jacob","year":"2019","journal-title":"Front. Mol. Neurosci."},{"issue":"9","key":"10.1016\/j.neurobiolaging.2024.12.001_bib26","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S1474-4422(23)00128-X","article-title":"The complex pathway between amyloid \u03b2 and cognition: implications for therapy","author":"Jagust","year":"2023","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2024.12.001_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21020563","article-title":"Molecular and regulatory mechanisms of desensitization and resensitization of GABA(A) receptors with a special reference to propofol\/barbiturate.","author":"Kang","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2024.12.001_bib28","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ncl.2007.03.008","article-title":"Alzheimer's disease and mild cognitive impairment","author":"Kelley","year":"2007","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.neurobiolaging.2024.12.001_bib29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neuropharm.2012.06.023","article-title":"Selective G.A.B.A.(A.) \u03b15 positive allosteric modulators improve cognitive function in aged rats with memory impairment","volume":"1","author":"Koh","year":"2013","journal-title":"Neuropharmacology"},{"issue":"S3","key":"10.1016\/j.neurobiolaging.2024.12.001_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/alz.063886","article-title":"Loss of large dendritic spines during normal aging is mediated by alterations in discrete protein networks within the precuneus","author":"Krivinko","year":"2022","journal-title":"Alzheimer's. Dement."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2024.12.001_bib31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0149-7634(01)00041-0","article-title":"The neurobiological basis of spontaneous alternation","author":"Lalonde","year":"2002","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2024.12.001_bib32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer's disease","author":"Lane","year":"2018","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2024.12.001_bib33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13195-021-00809-4","article-title":"A comparative study of the effects of Aducanumab and scanning ultrasound on amyloid plaques and behavior in the APP23 mouse model of Alzheimer disease","author":"Leinenga","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neurobiolaging.2024.12.001_bib34","article-title":"Reduced brain somatostatin in mood disorders: a common pathophysiological substrate and drug target?","volume":"110","author":"Lin","year":"2013","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.neurobiolaging.2024.12.001_bib35","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.clinthera.2021.05.006","article-title":"Modifiable risk factors in Alzheimer disease and related dementias: a review","author":"Litke","year":"2021","journal-title":"Clin. Ther."},{"issue":"9","key":"10.1016\/j.neurobiolaging.2024.12.001_bib36","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.tips.2023.06.009","article-title":"GABA(A) receptors as targets for treating affective and cognitive symptoms of depression.","author":"Luscher","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"issue":"9","key":"10.1016\/j.neurobiolaging.2024.12.001_bib37","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.tips.2023.06.009","article-title":"GABAA receptors as targets for treating affective and cognitive symptoms of depression","author":"Luscher","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.neurobiolaging.2024.12.001_bib38","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1523\/JNEUROSCI.0567-18.2018","article-title":"Input-specific synaptic location and function of the \u03b15 GABA(A) receptor subunit in the mouse CA1 hippocampal neurons","author":"Magnin","year":"2019","journal-title":"J. Neurosci."},{"issue":"175","key":"10.1016\/j.neurobiolaging.2024.12.001_bib39","doi-asserted-by":"crossref","DOI":"10.3791\/62593","article-title":"Handling techniques to reduce stress in mice","author":"Marcotte","year":"2021","journal-title":"J. Vis. Exp."},{"issue":"20","key":"10.1016\/j.neurobiolaging.2024.12.001_bib40","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1016\/j.cell.2023.08.039","article-title":"Single-cell atlas reveals correlates of high cognitive function, dementia, and resilience to Alzheimer's disease pathology","author":"Mathys","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.neurobiolaging.2024.12.001_bib41","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0306-4530(93)90044-L","article-title":"CSF somatostatin in Alzheimer\u2019s disease and major depression: relationship to hypothalamic-pituitary-adrenal axis and clinical measures","volume":"7","author":"Molchan","year":"1993","journal-title":"Psychoneuroendocrinology"},{"issue":"s1","key":"10.1016\/j.neurobiolaging.2024.12.001_bib42","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-179928","article-title":"Amyloid accumulation and cognitive decline in clinically normal older individuals: implications for aging and early Alzheimer's disease","author":"Mormino","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"6006","key":"10.1016\/j.neurobiolaging.2024.12.001_bib43","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/314090a0","article-title":"Somatostatin immunoreactivity in neuritic plaques of Alzheimer's patients","author":"Morrison","year":"1985","journal-title":"Nature"},{"issue":"40","key":"10.1016\/j.neurobiolaging.2024.12.001_bib44","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation","author":"Oakley","year":"2006","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.neurobiolaging.2024.12.001_bib45","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nn.2583","article-title":"Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks.","author":"Palop","year":"2010","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2024.12.001_bib46","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nn.2741","article-title":"Dendritic spine pathology in neuropsychiatric disorders","author":"Penzes","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2024.12.001_bib47","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.arr.2016.01.002","article-title":"Brain atrophy in Alzheimer\u2019s Disease and aging","author":"Pini","year":"2016","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2024.12.001_bib48","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41380-020-0727-3","article-title":"Altered GABA-mediated information processing and cognitive dysfunctions in depression and other brain disorders","author":"Prevot","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2024.12.001_bib49","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1021\/acschemneuro.9b00148","article-title":"Insight into novel treatment for cognitive dysfunctions across disorders","author":"Prevot","year":"2019","journal-title":"ACS Chem. Neurosci."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2024.12.001_bib50","first-page":"84","article-title":"Novel benzodiazepine-like ligands with various anxiolytic, antidepressant, or pro-cognitive profiles","author":"Prevot","year":"2019","journal-title":"Mol. Neuropsychiatry"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2024.12.001_bib51","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/cercor\/bhaa310","article-title":"Reversal of age-related neuronal atrophy by \u03b15-GABAA receptor positive allosteric modulation","author":"Prevot","year":"2021","journal-title":"Cereb. Cortex"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2024.12.001_bib52","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/cercor\/bhaa310","article-title":"Reversal of age-related neuronal atrophy by alpha5-GABAA receptor positive allosteric modulation","author":"Prevot","year":"2021","journal-title":"Cereb. Cortex"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2024.12.001_bib53","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.3162","article-title":"Assessing spatial working memory using the spontaneous alternation Y-maze test in aged male mice","author":"Prieur","year":"2019","journal-title":"Bio Protoc."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2024.12.001_bib54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13024-019-0356-y","article-title":"Contribution of GABAergic interneurons to amyloid-\u03b2 plaque pathology in an APP knock-in mouse model","author":"Rice","year":"2020","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2024.12.001_bib55","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.coph.2005.10.003","article-title":"GABA-based therapeutic approaches: GABAA receptor subtype functions","author":"Rudolph","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"issue":"28","key":"10.1016\/j.neurobiolaging.2024.12.001_bib56","doi-asserted-by":"crossref","first-page":"16096","DOI":"10.1073\/pnas.2010281117","article-title":"How synaptic pruning shapes neural wiring during development and, possibly, in disease","author":"Sakai","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neurobiolaging.2024.12.001_bib57","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000012451","article-title":"Aducanumab, amyloid lowering, and slowing of Alzheimer disease","author":"Salloway","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2024.12.001_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2021.113578","article-title":"Positive modulation of \u03b15GABAA receptors leads to dichotomous effects in rats on memory pattern and GABRA5 expression in prefrontal cortex and hippocampus","author":"Santra\u010d","year":"2022","journal-title":"Behav. Brain Res."},{"issue":"7618","key":"10.1016\/j.neurobiolaging.2024.12.001_bib59","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease","author":"Sevigny","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2024.12.001_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19336896.2017.1405207","article-title":"Somatostatin in Alzheimer's disease: a new role for an old player","author":"Solarski","year":"2018","journal-title":"Prion"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2024.12.001_bib61","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1212\/WNL.37.1.161","article-title":"Alzheimer's disease: low cerebral somatostatin levels correlate with impaired cognitive function and cortical metabolism","author":"Tamminga","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2024.12.001_bib62","doi-asserted-by":"crossref","DOI":"10.7573\/dic.2021-7-3","article-title":"Aducanumab: evidence from clinical trial data and controversies","author":"Tampi","year":"2021","journal-title":"Drugs Context"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2024.12.001_bib63","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neuron.2016.06.033","article-title":"GABAergic interneurons in the neocortex: from cellular properties to circuits","author":"Tremblay","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2024.12.001_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173554","article-title":"Alzheimer's disease: recent treatment strategies","author":"Vaz","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2024.12.001_bib65","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/13543784.2023.2178414","article-title":"Lecanemab (BAN2401): an anti\u2013beta-amyloid monoclonal antibody for the treatment of Alzheimer disease","author":"Vitek","year":"2023","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2024.12.001_bib66","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1038\/s41598-023-29559-z","article-title":"Somatostatin slows Abeta plaque deposition in aged APP(NL-F\/NL-F) mice by blocking Abeta aggregation.","author":"Williams","year":"2023","journal-title":"Sci. Rep."},{"issue":"18","key":"10.1016\/j.neurobiolaging.2024.12.001_bib67","doi-asserted-by":"crossref","first-page":"7141","DOI":"10.1073\/pnas.0402147101","article-title":"Selective vulnerability of dentate granule cells prior to amyloid deposition in PDAPP mice: digital morphometric analyses","author":"Wu","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neurobiolaging.2024.12.001_bib68","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3389\/fnins.2020.00660","article-title":"GABAergic inhibitory interneuron deficits in Alzheimer's disease: implications for treatment","author":"Xu","year":"2020","journal-title":"Front. Neurosci."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2024.12.001_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110232","article-title":"Reduced inhibition in depression impairs stimulus processing in human cortical microcircuits","author":"Yao","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.neurobiolaging.2024.12.001_bib70","article-title":"Somatostatin-expressing inhibitory interneurons in cortical circuits","volume":"76","author":"Yavorska","year":"2016","journal-title":"Front. Neural Circuits"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2024.12.001_bib71","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","article-title":"Amyloid \u03b2-based therapy for Alzheimer\u2019s disease: challenges, successes and future","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458024002136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458024002136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T08:58:56Z","timestamp":1750755536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458024002136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":71,"alternative-id":["S0197458024002136"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2024.12.001","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Procognitive and neurotrophic benefits of \u03b15-GABA-A receptor positive allosteric modulation in a \u03b2-amyloid deposition mouse model of Alzheimer\u2019s disease pathology","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2024.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}